Cameco insider plans sale of 25,000 common shares on NYSE

Cameco Corporation has a notice to sell 25,000 common shares.

Accepted by SEC EDGAR 01/07/2026 - 07:44 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Cameco Corporation has a notice to sell 25,000 common shares. The planned sale is listed through broker Solium Financial Inc. on the NYSE, with an approximate sale date of 01/07/2026 and an aggregate market value of 2,598,500.00. These 25,000 shares were acquired on the same date via a stock option exercise paid in cash.

During the past three months, Timothy S. Gitzel sold 50,000 common shares on 01/02/2026 for gross proceeds of 4,928,000.00 and another 50,000 shares on 12/19/2025 for 4,499,500.00. Shares outstanding were 435,457,978; this is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Cameco (CCJ) disclose in this Form 144 notice?

The notice covers a planned sale of 25,000 Cameco common shares on or about 01/07/2026, acquired the same day via a cash stock option exercise.

How many Cameco (CCJ) shares are planned to be sold and on which exchange?

The filing lists 25,000 common shares to be sold on the NYSE through broker Solium Financial Inc. with an aggregate market value of 2,598,500.00.

How were the 25,000 Cameco (CCJ) shares acquired before this planned sale?

The 25,000 shares were acquired on 01/07/2026 through a stock option exercise from Cameco Corporation, with payment made in cash.

What recent Cameco (CCJ) share sales by Timothy S. Gitzel are disclosed?

The notice shows Timothy S. Gitzel sold 50,000 common shares on 01/02/2026 for 4,928,000.00 and another 50,000 shares on 12/19/2025 for 4,499,500.00.

How many Cameco (CCJ) shares are reported as outstanding in this notice?

The document lists 435,457,978 common shares outstanding, which serves as a baseline figure alongside the 25,000 shares planned for sale.

Who is the broker handling the planned Cameco (CCJ) share sale?

The broker named is Solium Financial Inc., located in Calgary, which is listed for the planned sale of 25,000 Cameco common shares on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001588386
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAMECO CORP
SEC File Number	001-14228
Address of Issuer	2121 11TH ST W SASKATOON SASKATCHEWAN, CANADA S7M 1J3
Phone	3069566200
Name of Person for Whose Account the Securities are To Be Sold	Gitzel Timothy S.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Solium Financial Inc. 1500, 800 - 6th Avenue SW Calgary A9 T2P 3G3	25000	2598500.00	435457978	01/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	01/07/2026	Stock Option Exercise	Cameco Corporation			25000	01/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Timothy S. Gitzel 2121 11th Street West Saskatoon A9 S7M 1J3	Common Shares	01/02/2026	50000	4928000.00
Timothy S. Gitzel 2121 11th Street West Saskatoon A9 S7M 1J3	Common Shares	12/19/2025	50000	4499500.00

144: Remarks and Signature

Remarks
Date of Notice	01/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Timothy S. Gitzel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)